Results 131 to 140 of about 13,185 (147)

Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies

Molecular Therapy, 2022
Elodie Leroux, Romain Perbet, Raphaelle Caillierez   +2 more
exaly  

Tau and MAPT genetics in tauopathies and synucleinopathies

Parkinsonism and Related Disorders, 2021
Etienne Leveille, Owen A Ross, Ziv Gan-Or   +2 more
exaly  

Increased G3BP2-Tau interaction in tauopathies is a natural defense against Tau aggregation

Neuron, 2023
Congwei Wang, Ravi Jagasia
exaly  

Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies

Expert Opinion on Investigational Drugs, 2023
Francesco Panza, Vittorio Dibello, Roberta Stallone   +2 more
exaly  

Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [18F]PI-2620 on Tau Filaments from 3R/4R and 4R Tauopathies

ACS Chemical Neuroscience, 2022
Michael Rullmann, Henryk Barthel, Matthias Brendel   +2 more
exaly  

In Vivo Assessment of Neuroinflammation in 4‐Repeat Tauopathies

Movement Disorders, 2021
Carla Palleis, Julia Sauerbeck, Leonie Beyer   +2 more
exaly  

O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer’s disease and related tauopathies: analysis of the patent literature

Expert Opinion on Therapeutic Patents, 2021
Andres A Trabanco, Peter Buijnsters
exaly  

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

International Journal of Molecular Sciences, 2021
Józef Hanes
exaly  

Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies

International Journal of Environmental Research and Public Health, 2020
Jan Aaseth, Aleksandra Buha Djordjevic, David R Wallace   +2 more
exaly  

mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies

Aging Cell, 2013
Antonella Caccamo, Andrea Magri, Manuel F Lopez-Aranda   +2 more
exaly